BIOVIE INC (BIVI) Stock Income Statement
USA - NASDAQ:BIVI - US09074F5044 - Common Stock
1.61 USD
+0.1 (+6.62%)
1.54 USD
-0.07 (-4.35%)
| 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 17.60M | 32.18M | 45.08M | 27.25M | 138.05M | |||
| Research and Development | 9.27M | 23.10M | 33.30M | 17.26M | 133.19M | |||
| Selling, General, and Administrative Expenses | 8.10M | 8.86M | 11.55M | 9.77M | 4.64M | |||
| Operating Income | -17.60M | -32.18M | -45.08M | -27.25M | -138.05M | |||
| Interest Income/Expense | 524.10K | 59.10K | -5.18M | 1.17M | 7.74M | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | -468.00K | 5.20K | null | 0 | 60.00K | |||
| Income Before Taxes | -17.54M | -32.12M | -50.26M | -26.08M | -130.25M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -17.91M | -33.01M | -50.26M | -26.08M | -183.85M | |||
| EBITDA | -17.37M | -31.96M | -44.85M | -27.02M | -137.82M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -12.124 | -73.048 | -154.72 | -105.74 | -1.48K | |||
| Non GAAP EPS | null | null | -15.600000000000001 | null | null | |||
| Statistics | ||||||||
All data in USD